A group of JUUL Labs investors has raised concerns about a financial relief transaction conducted by JUUL board members Nick Pritzker and Riaz Valani in November 2022, according to The Wall Street Journal. They allege that the deal has benefited insiders while harming the interests of other investors.
As a pioneer in the e-cigarette industry, JUUL Labs has shifted from dominating the American market to fighting for survival in a short period of time. After achieving initial success, the company faced regulatory scrutiny due to its marketing practices. Thousands of lawsuits alleging that the company facilitated an "epidemic" of e-cigarette use among minors have notably impacted its financial situation.
JUUL is considering bankruptcy since June 2022, after the FDA ordered the removal of its e-cigarettes from the market and obtained a court injunction.
In order to avoid bankruptcy, Pritzker and Valani refinanced JUUL's loan deadlines in September 2022 and subsequently loaned funds to cover operational costs during the autumn. Finally, the two directors, along with JUUL's co-founders James Monsees and Adam Bowen, supported a comprehensive legal and investment agreement, which involved equity investment in JUUL.
JUUL successfully raised $1.27 billion in funding in October 2023, after engaging with numerous potential investors. This funding includes an additional $45 million investment from Pritzker, Valani, and two co-founders of JUUL, as well as legal entities associated with JUUL and four other investors.
Entities associated with Valani and Pritzker now collectively hold nearly half of JUUL's shares, while the majority of other investors have significantly reduced their holdings during the crisis.
D1 Capital Partners, an affiliate of hedge fund, along with two other investors, filed a lawsuit against JUUL in October 2023, alleging that Pritzker and Valani "exploited the company's distress to further their own personal interests, thereby harming other stakeholders of JUUL.
JUUL plans to raise $330 million in 2024 to maintain its existing product line in the US market and submit new e-cigarette products for federal authorization.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
